![Zorbtive [somatropin (rDNA origin) for injection]](images/Zorbtive_180.png)
Why SBS may need specialized treatment
Living with
parenteral nutrition
Zorbtive is the latest treatment advance
 |
| “Any treatment that may reduce my need for PN needs to be carefully considered.” |
Zorbtive® [somatropin (rDNA origin) for injection] is the latest treatment advance for people with Short Bowel Syndrome who are receiving specialized nutritional support.
Zorbtive may improve the ability of your small intestine to absorb nutrients and fluids from your oral diet.
This in turn may lead to less need for parenteral nutrition (PN).
The important first step is to explore your treatment options for SBS.
Your doctor will evaluate your condition and may decide to prescribe Zorbtive.
The goal of Zorbtive treatment together with a special oral diet...
- reduced need for PN
The potential of less PN...
- improved lifestyle
- less PN-related side effects, some of which can be serious
What defines SBS
Why SBS may need specialized treatment
Living with parenteral nutrition
Zorbtive is the latest treatment advance
Home
Zorbtive® [somatropin (rDNA origin) for injection] is indicated for the treatment of Short Bowel Syndrome (SBS) in patients receiving specialized nutritional support. Optimal management of SBS may include dietary adjustments, enteral feedings, parenteral nutrition, and fluid and micronutrient supplements, as needed.
Some common side effects of Zorbtive treatment include muscle and joint pain, and fluid retention (swelling).
Zorbtive may also cause serious side effects such as inflammation of the pancreas (pancreatitis), diabetes or
other blood sugar problems, pain, numbness or tingling in the wrist and hand, or increased blood pressure
in the brain. Make sure and talk with your doctor about these side effects.
Do not take Zorbtive if you have any of the following serious medical conditions: open-heart surgery; stomach-area (abdominal) surgery; an accident; breathing problems (respiratory failure); cancer; or, allergy to Zorbtive or other growth hormone medications.
This information is not intended to replace discussions with your healthcare professional.
For additional information about Zorbtive, please read the Zorbtive Patient Information Leaflet
and Zorbtive Full Prescribing Information and talk to your doctor. You can also call SeroCareSM
toll free at 800-714-2437. Zorbtive is available by prescription only.
This Web site was developed by EMD Serono, Inc. (emdserono.com), makers of Zorbtive, to educate SBS patients
and interested healthcare professionals about this treatment for Short Bowel Syndrome.
This site contains medical information that is intended for residents of the United States
only and is not meant to substitute for the advice provided by a medical professional.
Always consult a doctor if you have health concerns. Use and access of this
site is subject to the terms and conditions as set out in our Legal Statement
and Privacy Policy.
© 2007 EMD Serono, Inc. All rights reserved. 